HASEGAWA, T., YANAGITANI, N., NINOMIYA, H., SAKAMOTO, H., TOZUKA, T., YOSHIDA, H., . . . NISHIO, M. (2020). Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer. In Vivo.
Chicago Style CitationHASEGAWA, TSUKASA, et al. "Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer." In Vivo 2020.
MLA CitationHASEGAWA, TSUKASA, et al. "Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer." In Vivo 2020.
Warning: These citations may not always be 100% accurate.